Neurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative[...]
Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
Significant Productivity Improvements Achieved for Client Using Vuzix[...]
09/20/2021 | Press release | Distributed by Public on 09/20/2021 14:37
Please select the service you want to use:
Smartlinks | Outset Medical Inc. | News | Health | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Shareholders | Internal Dealings | Public Companies | Medical Technology Companies | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact